Are there medulloblastoma clinical trials in North Carolina?

Yes. We're currently tracking 4 recruiting medulloblastoma studies with a site in North Carolina, each rewritten in plain language so you can see what it's testing and who it's for.

How do I find out if I qualify for a medulloblastoma study in North Carolina?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in North Carolina to take part?

Not necessarily. These studies have a site in North Carolina, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a medulloblastoma trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · North Carolina

Medulloblastoma clinical trials in North Carolina

We’re tracking 4 recruiting medulloblastoma studies with a site in North Carolina — including Phase 2 and Phase 3 studies, each written for real people, not researchers.

Recruiting studies in North Carolina

NCT06701812RecruitingPhase 2
Digoxin for relapsed non-WNT non-SHH medulloblastoma
This trial tests whether the drug digoxin can help treat medulloblastoma that has come back after standard treatments like chemotherapy and radiation. Digoxin is a heart medicine being studied for its anticancer effects against a specific type of medulloblastoma.
Chapel Hill, North CarolinaAges 1–30
NCT04696029RecruitingPhase 2
DFMO to prevent return of high-risk or relapsed medulloblastoma
This Phase 2 study tests DFMO (a maintenance medicine) to help stop medulloblastoma from coming back or worsening after prior treatment. It focuses on children and young people with specific high-risk tumor types or tumors that have returned or not responded well to treatment.
Charlotte, North CarolinaAges Up to 21 years
NCT05382338RecruitingPhase 3
Sodium thiosulfate to protect hearing in medulloblastoma
This Phase 3 study tests whether adding sodium thiosulfate during treatment for newly diagnosed medulloblastoma can reduce the risk of hearing loss. It is designed for children and teens whose cancer meets specific low-risk or average-risk tumor and lab features.
Chapel Hill, North CarolinaAges 4–21
NCT05096481RecruitingPhase 2
Vaccine trial for children with certain brain tumors
This Phase 2 study tests a vaccine made to target CMV (a virus) in order to treat children with medulloblastoma or newly diagnosed high-grade glioma/DIPG. If you’re eligible, you’d receive the study vaccine and the team would closely watch how well it’s tolerated and how your cancer responds.
Durham, North CarolinaAges 3–39

Where these studies are running in North Carolina

Institutions with a site for the recruiting medulloblastoma studies listed above.

UNC Lineberger Comprehensive Cancer Center · 2 studies
Carolinas Medical Center/Levine Cancer Institute
Duke Cancer Center
Duke University
East Carolina University
Levine Cancer Institute
Levine Children's Hospital
Wake Forest University Health Sciences

What taking part in a medulloblastoma study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Medulloblastoma trials in other states

Common questions

Are there medulloblastoma clinical trials in North Carolina?: Yes. We're currently tracking 4 recruiting medulloblastoma studies with a site in North Carolina, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a medulloblastoma study in North Carolina?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in North Carolina to take part?: Not necessarily. These studies have a site in North Carolina, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a medulloblastoma trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New medulloblastoma studies open in North Carolina regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.